Clinical Executives The Rise of Healthcare’s New Leaders

whitePaper | August 3, 2022

Stages 1 and 2 of the Meaningful Use guidelines incented healthcare organizations to adopt EHR technology, but they did not offer best practices for how the accumulated patient data should be handled.

whitePaper | August 25, 2022

The revenue cycle process has a long and cumbersome history that continues to become more complex as policies, payer relationships, and patient expectations evolve.

whitePaper | March 4, 2020

Health leaders must understand the benefits of their investments in performance improvement projects and the impact on the organization. The traditional approach is most often to measure ROI (return on investment) and, while clearly measurable, is most often related to cost savings or increased revenue and can leave you with an incomplete story. Incorporating VOI (value on investment) enables you to quantify the intangible benefits of your projects and activities making the combination of the two a more robust indicator of project success.

whitePaper | December 27, 2022

Year after year, the Life Sciences industry expands at a breakneck pace, with pharmaceutical development leading the way. Regulatory agencies prioritize patient safety in this highly regulated industry.

whitePaper | April 28, 2022

The authors would like to express their gratitude to those who contributed to this research either by participating in the surveys carried out during the EIT Health Morning Health Talks or the in-depth interviews.

whitePaper | February 22, 2023

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier.